Overview
Bayer of Leverkusen, Germany, operates in health care and nutrition through three segments: Crop Science, Pharmaceuticals and Consumer Health.[2] Forbes records sales of US$52.4bn and a loss of US$2.5bn, the largest loss in this ranking, and a market value of US$43.1bn, the lowest among the top fifteen.[2] Crop Science sells seeds, plant traits and crop-protection products, so a large share of Bayer’s revenue is agricultural rather than pharmaceutical; it is included because Forbes classifies the group as a drugs and biotechnology company. The Pharmaceuticals segment sells cardiology and women’s-health products, oncology, haematology, ophthalmology and cell and gene therapy, as well as diagnostic imaging, and Consumer Health sells non-prescription products.[2] Bayer fell from seventh to ninth place on the prior-year comparison, as Eli Lilly and Novartis moved ahead of it.
Bayer AG strengths and limitations
Strengths
- Diversified across agriculture and health
- Large consumer-health brand portfolio
- 88,078 employees
Limitations
- Net loss of US$2.5bn
- Much of its revenue is agricultural
- Lowest market value among the top fifteen
Appears in
Bayer AG peers and competitors
Companies ranked in the same lists as Bayer AG.
Volkswagen Group- Amgen
Merck & Co.
Pfizer- AbbVie
AstraZeneca PLC
Novartis
Novo Nordisk
Sanofi- Bristol Myers Squibb
GSK plc
Takeda Pharmaceutical
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.